Brendan J Jenkins

14PUBLICATIONS
24CO-AUTHORS
Cancer diagnosisInnate immunityMolecular targetsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 07, 2026
Cancer cell-intrinsic inflammasome protein ASC links innate immunity with mitochondrial metabolism in driving pancreatic cancer.

Yu C J Chey, Bassam Kashgari, Louise McLeod

|Nov 08, 2024
The Role of Inflammasome-Associated Innate Immune Receptors in Cancer.

Ruby E Dawson, Brendan J Jenkins

|Apr 10, 2024
Cytosolic DNA sensor AIM2 promotes KRAS-driven lung cancer independent of inflammasomes.

Mohammad Alanazi, Teresa Weng, Louise McLeod

|Aug 04, 2023
The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond.

Mohamed I Saad, Brendan J Jenkins

|Apr 17, 2023
Targeting IL-6 trans-signalling: past, present and future prospects.

Stefan Rose-John, Brendan J Jenkins, Christoph Garbers

|Mar 31, 2022
Context-dependent functions of pattern recognition receptors in cancer.

Si Ming Man, Brendan J Jenkins

Pageof 3

Frequent Collaborators

6 joint publications

Mohamed I Saad

2 joint publications

Linden J Gearing

1 joint publications

Gareth W Jones

1 joint publications

Ji Kun Li